A diet rich in pomegranates had significant positive impacts for the brain health of mice with Alzheimer’s disease, an international research team led by the Centre for Healthy Brain Ageing (CHeBA) at UNSW found.
The innovative study, published in the journal Oncotarget, demonstrated that dietary supplementation of 4% pomegranate extract to a standard diet over a 15-month period resulted in a range of neuroprotective effects in mice.
Bred to provide a model of Alzheimer’s disease, the mice demonstrate progressive age-related brain decline linked to the build-up of amyloid-beta (Aß) protein in the brain.
